Neoplasm Treatment Market Outlook:
Neoplasm Treatment Market size was over USD 241.74 billion in 2025 and is poised to exceed USD 638.51 billion by 2035, growing at over 10.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of neoplasm treatment is evaluated at USD 263.93 billion.
The growth of the market can be attributed to the increasing number of peoples suffering from malignant tumors, followed by the rising number of cases across the globe. According to the data by the World Health Organization (WHO), over 10 million people died due to cancer in 2020, up from 9.6 million in 2018. Moreover, there were 2.26 million new cases of breast cancer, 2.21 million cases of lung cancer, and 1.41 million cases of prostate cancer in 2020 itself.
Neoplasms can be cancerous or non-cancerous growths in different organs of the body. Neoplasm is not swelling as in case of tumors, and a new unwanted growth. The factors causing the non-cancerous neoplasm are often unknown, as it doesn’t spread to other parts of the body. On the other hand, there are few factors that are linked to the growth of the cancerous neoplasm such as rise in the exposure to skin or toxin chemical. For instance, as per the American Academy of Dermatology Association estimated, nearly one in five Americans develops skin cancer in their lifetime.
